Draft Genome Sequence of a Serratia marcescens Strain Isolated from a Preterm Neonatal Blood Sepsis Patient at the Royal Infirmary, Edinburgh, Scotland, United Kingdom.

K A Kropp,A Lucid,C Smith,R D Sleator,B Kelly,A O'Driscoll,P Ghazal,K Templeton,P Dickinson,V Belgrudov,P Walsh,J Carroll

doi:10.1128/genomea.00908-14

Abstract

Herein, we report the draft genome sequence for isolate ED-NGS-1015 of Serratia marcescens, cultivated from a blood sample obtained from a neonatal sepsis patient at the Royal Infirmary in Edinburgh, Scotland, United Kingdom.

Highlights

We report the draft genome sequence for isolate ED-NGS-1015 of Serratia marcescens, cultivated from a blood sample obtained from a neonatal sepsis patient at the Royal Infirmary in Edinburgh, Scotland, United Kingdom
The ClouDx-i project aims to extend our knowledge of currently circulating pathogenic strains linked with blood sepsis in neonates to inform the development of new molecular diagnostic assays
We present the draft genome of a Serratia marcescens strain isolated from a preterm neonate in Edinburgh in 2013

Summary

Introduction

We report the draft genome sequence for isolate ED-NGS-1015 of Serratia marcescens, cultivated from a blood sample obtained from a neonatal sepsis patient at the Royal Infirmary in Edinburgh, Scotland, United Kingdom. Serratia marcescens is a Gram-negative, rare, but clinically important nosocomial pathogen that causes meningitis and blood sepsis [1,2,3]. Preterm neonates are a highly susceptible patient group for bacterial infections [4,5,6] and rapid detection of blood sepsis and the causative agent are critical first steps to enable proper treatment [7,8,9]. The ClouDx-i project aims to extend our knowledge of currently circulating pathogenic strains linked with blood sepsis in neonates to inform the development of new molecular diagnostic assays.

Results

Conclusion